We have recently reported a homogeneous, nonradioactive fluorescence p
olarization method to assay protein tyrosine kinase activity. Our orig
inal approach can only be used with a peptide substrate and requires l
arge amounts of anti-phosphotyrosine antibody. To overcome these probl
ems an alternate fluorescence polarization competition immunoassay was
designed and evaluated. In this assay, phosphorylated peptide or prot
ein produced by kinase reaction will compete with a fluorescent phosph
opeptide used as a tracer for immunocomplex formation with phosphotyro
sine antibody. In this format kinase activity will result in the loss
of the polarization signal. To validate the fluorescence polarization
competition immunoassay, Lck activity was compared with a more commonl
y used (PO4)-P-32-transfer assay using Lck peptide or enolase as the s
ubstrate. In both the assays, Lck activity showed a similar dependence
on ATP, Lck enzyme, and the peptide/enolase substrate concentrations
with the FP signal inversely proportional to the amount of (PO4)-P-32
transferred to the substrate. Inhibition by staurosporine and the Lck
inhibitor methylphenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine was simil
ar in these two assays. The advantages of this assay over other kinase
assays include use of nonisotopic substrates and a more simple proced
ure in which the kinase assay is done in a single tube (well of a micr
otiter plate), without separation, precipitation, or washing. This met
hod is easily automated for high-throughput drug discovery screening.
(C) 1998 Academic Press.